Berndt Modig
CIK 1643072 · Chief Executive Officer · last filed 2026-05-22
Berndt Modig is a Chief Executive Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for PHVS, was dated May 22, 2026. Across all open-market trades the lifetime net is −$779.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $33.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$33.41M
3
11
-$779.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHVS | Chief Executive Officer | 1,087,500 | $30.72 | $33.41M | -$779.8K | 4 | 2026-05-22 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Director | — | $0.48 | — | $0 | 1 | 2021-04-19 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Director | — | — | — | $0 | 1 | 2020-04-17 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | PHVS | — | — | $0 | EDGAR |
| 2026-05-20 | PHVS | Sell (S) | −2,292 | -$67.0K | EDGAR |
| 2026-04-20 | PHVS | Sell (S) | −2,292 | -$65.6K | EDGAR |
| 2026-04-10 | PHVS | Sell (S) | −23,333 | -$647.3K | EDGAR |
| 2021-04-19 | Sio Gene Therapies Inc. (SIOX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-17 | Sio Gene Therapies Inc. (AXGT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | — | Grant (A) | — | $0 | |
| 2018-03-16 | — | Grant (A) | — | $0 | |
| 2018-01-03 | — | Exer (M) | +77,914 | $70.1K | |
| 2017-05-02 | — | Grant (A) | — | $0 |